In a piece published in British newspaper The Daily Mail, psychiatrist David Healy claims pharmaceutical companies commonly use deceptive tactics to manipulate clinical trials for new drugs. As a result, Healy alleges, health regulatory agencies approve drugs that are not only ineffective, but dangerous for patients who use them.
He writes that the corporate tactics include the following:
- Conducting clinical trials and not publishing any negative results that come out of ...